董秋美, 马冬, 徐飞. 奥拉帕利用于gBRCA基因突变转移性胰腺癌的维持治疗[J]. 循证医学, 2019, 19(5): 261-263. DOI: 10.12019/j.issn.1671-5144.2019.05.002
    引用本文: 董秋美, 马冬, 徐飞. 奥拉帕利用于gBRCA基因突变转移性胰腺癌的维持治疗[J]. 循证医学, 2019, 19(5): 261-263. DOI: 10.12019/j.issn.1671-5144.2019.05.002
    DONG Qiu-mei, MA Dong, XU Fei. Maintenance Olaparib for gBRCA-Mutated Metastatic Pancreatic Cancer[J]. Journal of Evidence-Based Medicine, 2019, 19(5): 261-263. DOI: 10.12019/j.issn.1671-5144.2019.05.002
    Citation: DONG Qiu-mei, MA Dong, XU Fei. Maintenance Olaparib for gBRCA-Mutated Metastatic Pancreatic Cancer[J]. Journal of Evidence-Based Medicine, 2019, 19(5): 261-263. DOI: 10.12019/j.issn.1671-5144.2019.05.002

    奥拉帕利用于gBRCA基因突变转移性胰腺癌的维持治疗

    Maintenance Olaparib for gBRCA-Mutated Metastatic Pancreatic Cancer

    /

    返回文章
    返回